Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 20 studies | 48% ± 14% | |
lung | 18 studies | 51% ± 12% | |
intestine | 14 studies | 44% ± 19% | |
eye | 11 studies | 53% ± 19% | |
kidney | 9 studies | 52% ± 15% | |
liver | 9 studies | 40% ± 16% | |
bone marrow | 7 studies | 40% ± 17% | |
lymph node | 7 studies | 54% ± 16% | |
brain | 7 studies | 32% ± 11% | |
uterus | 6 studies | 62% ± 16% | |
pancreas | 5 studies | 41% ± 11% | |
placenta | 4 studies | 68% ± 22% | |
prostate | 4 studies | 54% ± 6% | |
skin | 4 studies | 70% ± 16% | |
breast | 4 studies | 64% ± 5% | |
ovary | 3 studies | 41% ± 2% | |
heart | 3 studies | 33% ± 11% | |
adipose | 3 studies | 41% ± 16% | |
adrenal gland | 3 studies | 53% ± 9% | |
esophagus | 3 studies | 68% ± 14% | |
thymus | 3 studies | 68% ± 24% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 29740.17 | 1443 / 1445 | 100% | 555.36 | 183 / 183 |
intestine | 100% | 24838.71 | 966 / 966 | 99% | 483.86 | 524 / 527 |
breast | 100% | 30457.19 | 459 / 459 | 99% | 391.93 | 1110 / 1118 |
lung | 99% | 22656.07 | 575 / 578 | 100% | 506.73 | 1152 / 1155 |
skin | 100% | 60471.22 | 1808 / 1809 | 99% | 534.17 | 467 / 472 |
kidney | 99% | 28248.84 | 88 / 89 | 96% | 698.30 | 869 / 901 |
bladder | 100% | 24586.00 | 21 / 21 | 94% | 388.97 | 475 / 504 |
uterus | 95% | 13837.19 | 161 / 170 | 99% | 467.85 | 455 / 459 |
thymus | 99% | 17606.75 | 647 / 653 | 94% | 186.39 | 566 / 605 |
liver | 97% | 35462.76 | 219 / 226 | 94% | 242.42 | 382 / 406 |
prostate | 91% | 15355.96 | 223 / 245 | 94% | 176.85 | 471 / 502 |
ovary | 84% | 12313.22 | 151 / 180 | 100% | 503.83 | 429 / 430 |
stomach | 74% | 13163.55 | 266 / 359 | 100% | 454.26 | 286 / 286 |
adrenal gland | 100% | 31023.19 | 258 / 258 | 66% | 200.60 | 151 / 230 |
pancreas | 62% | 7798.62 | 203 / 328 | 93% | 346.40 | 165 / 178 |
brain | 82% | 11296.74 | 2166 / 2642 | 53% | 139.79 | 371 / 705 |
adipose | 100% | 37451.95 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 436.53 | 29 / 29 |
tonsil | 0% | 0 | 0 / 0 | 100% | 519.90 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 95.47 | 1 / 1 |
blood vessel | 100% | 41577.95 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 46903.04 | 795 / 803 | 0% | 0 | 0 / 0 |
spleen | 99% | 16186.85 | 238 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 50005.36 | 908 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 311.04 | 78 / 80 |
heart | 90% | 20524.50 | 778 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006089 | Biological process | lactate metabolic process |
GO_0006096 | Biological process | glycolytic process |
GO_0006090 | Biological process | pyruvate metabolic process |
GO_1990204 | Cellular component | oxidoreductase complex |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0016020 | Cellular component | membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005634 | Cellular component | nucleus |
GO_0045296 | Molecular function | cadherin binding |
GO_0004459 | Molecular function | L-lactate dehydrogenase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | LDHA |
Protein name | L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (Cell proliferation-inducing gene 19 protein) (LDH muscle subunit) (LDH-M) (Renal carcinoma antigen NY-REN-59) L-lactate dehydrogenase A chain (LDH muscle subunit) Lactate dehydrogenase A |
Synonyms | PIG19 |
Description | FUNCTION: Interconverts simultaneously and stereospecifically pyruvate and lactate with concomitant interconversion of NADH and NAD(+). . |
Accessions | ENST00000539814.5 F5GYU2 ENST00000541097.5 F5H6W8 ENST00000673007.1 [P00338-3] ENST00000673083.1 [P00338-2] F5GXH2 ENST00000543695.5 ENST00000430553.6 [P00338-4] ENST00000542179.1 [P00338-1] ENST00000545467.5 ENST00000536528.5 ENST00000227157.8 [P00338-5] ENST00000673204.1 [P00338-1] F5H5J4 F5H8H6 ENST00000478970.6 F5GXC7 ENST00000379412.9 [P00338-3] ENST00000543445.5 ENST00000495052.5 ENST00000486690.6 F5GXY2 F5GWW2 F5GZQ4 ENST00000672405.1 [P00338-1] F5GXU1 ENST00000672078.1 [P00338-5] ENST00000535451.5 ENST00000396222.6 [P00338-2] ENST00000422447.8 [P00338-1] ENST00000545215.5 P00338 ENST00000671981.1 [P00338-1] ENST00000672996.1 [P00338-4] |